rss
Gut 1998;43:775-782 doi:10.1136/gut.43.6.775
  • Inflammation

Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat

  1. T Mahmuda,
  2. S Somasundarama,
  3. G Sigthorssona,
  4. R J Simpsona,
  5. S Rafia,
  6. R Fostera,
  7. I A Tavaresc,
  8. A Rosethf,
  9. A J Hutte,
  10. M Jacoba,
  11. J Pacya,
  12. D L Scottb,
  13. J M Wrigglesworthd,
  14. I Bjarnasona
  1. aDepartment of Medicine, King’s College School of Medicine and Dentistry, London, UK, bDepartment Rheumatology, King’s College School of Medicine and Dentistry, London, UK, cDepartment of Surgery, King’s College School of Medicine and Dentistry, London, UK, dDepartment of Pharmacy, King’s College, London, UK, eDepartments of Life Sciences and Electron Microscopy, King’s College, Kensington, London, UK, fDepartment of Medicine, Aker University Hospital, Oslo, Norway
  1. Dr I Bjarnason, Department of Medicine, King’s College School of Medicine and Dentistry, Bessemer Road, London SE5 9PJ, UK.
  • Accepted 4 June 1998

Abstract

Background—Non-steroidal anti-inflammatory drugs (NSAIDs) cause gastrointestinal damage by a non-prostaglandin (PG) dependent “topical” action and by inhibiting cyclooxygenase.

Aims—To discriminate between these two effects by studying some key pathophysiological steps in NSAID enteropathy following administration of (R)- and (S)-flurbiprofen, the racemic mixture, and an uncoupler, dinitrophenol.

Methods—The effects of dinitrophenol, racemic, (R)-, and (S)-flurbiprofen on mitochondria were assessed in vitro and on key pathophysiological features of small intestinal damage in vivo (ultrastructure by electron microscopy, mucosal prostanoid concentrations, intestinal permeability, inflammation, and ulcer count) in rats.

Results—All the drugs uncoupled mitochondrial oxidative phosphorylation in vitro, caused mitochondrial damage in vivo, and increased intestinal permeability. Dinitrophenol and (R)-flurbiprofen caused no significant decreases in mucosal prostanoid concentrations (apart from a decrease in thromboxane (TX) B2 concentrations following (R)-flurbiprofen) while racemic and (S)- flurbiprofen reduced mucosal prostanoids significantly (PGE, TXB2, and 6-keto-PGF1α concentrations by 73–95%). Intestinal inflammation was significantly greater following administration of (S)-flurbiprofen and racemate than with dinitrophenol and (R)-flurbiprofen. No small intestinal ulcers were found following dinitrophenol or (R)-flurbiprofen while both racemic and (S)-flurbiprofen caused numerous ulcers.

Conclusions—Dinitrophenol and (R)-flurbiprofen show similarities in their actions to uncouple mitochondrial oxidative phosphorylation in vitro, alter mitochondrial morphology in vivo, increase intestinal permeability, and cause mild inflammation without ulcers. Concurrent severe decreases in mucosal prostanoids seem to be the driving force for the development of severe inflammation and ulcers.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.